SEC Form 4 · accession 0001179110-19-001990
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin P Sutter
Director
Period of report
Feb 13, 2019
Accepted (ET)
Feb 15, 2019 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value | Feb 13, 2019 | S | 5,000 | $360.00 | D | 195,491 | D | |
| Common Stock, $0.01 par value | Feb 14, 2019 | S | 5,000 | $360.00 | D | 190,491 | D | |
| Common Stock, $0.01 par valueF2 | Feb 15, 2019 | S | 8,919 | $360.2275 | D | 181,572 | D | |
| Common Stock, $0.01 par value | Feb 15, 2019 | S | 1,081 | $361.00 | D | 180,491 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.67 | holding | — | — | — | Aug 11, 2010 | Aug 12, 2019 | Common Stock | 12,000 | 12,000 | D |
| Stock Option (right to buy)F1 | $9.99 | holding | — | — | — | Aug 10, 2011 | Aug 11, 2020 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F2This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $360.0000 and $360.6300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.